Focus on Portfolio Monetization and Roll-up Strategy
NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, is pleased to provide an update to its shareholders.
Read more at prnewswire.com